|
Index | - | P/E | - | EPS (ttm) | -3.30 | Insider Own | 0.40% | Shs Outstand | 6.45M | Perf Week | 13.44% |
Market Cap | 7.10M | Forward P/E | - | EPS next Y | -0.63 | Insider Trans | 108.19% | Shs Float | 5.77M | Perf Month | -22.11% |
Income | -9.80M | PEG | - | EPS next Q | -0.16 | Inst Own | 9.40% | Short Float | 3.39% | Perf Quarter | -81.03% |
Sales | 0.10M | P/S | 70.97 | EPS this Y | 109.40% | Inst Trans | -6.82% | Short Ratio | 0.23 | Perf Half Y | -63.90% |
Book/sh | 1.45 | P/B | 0.51 | EPS next Y | 4.80% | ROA | -157.30% | Target Price | 10.00 | Perf Year | -95.65% |
Cash/sh | 0.95 | P/C | 0.78 | EPS next 5Y | - | ROE | -217.00% | 52W Range | 0.59 - 20.00 | Perf YTD | -66.52% |
Dividend | - | P/FCF | - | EPS past 5Y | 15.00% | ROI | - | 52W High | -96.30% | Beta | 5.05 |
Dividend % | - | Quick Ratio | 24.30 | Sales past 5Y | - | Gross Margin | 46.70% | 52W Low | 25.21% | ATR | 0.10 |
Employees | 4 | Current Ratio | 24.30 | Sales Q/Q | 287.20% | Oper. Margin | - | RSI (14) | 36.14 | Volatility | 14.96% 14.23% |
Optionable | No | Debt/Eq | 0.00 | EPS Q/Q | -101.60% | Profit Margin | - | Rel Volume | 2.49 | Prev Close | 0.75 |
Shortable | Yes | LT Debt/Eq | 0.00 | Earnings | - | Payout | - | Avg Volume | 839.18K | Price | 0.74 |
Recom | 2.00 | SMA20 | -2.00% | SMA50 | -40.61% | SMA200 | -77.36% | Volume | 2,830,651 | Change | -1.33% |
![]() |
|
![]() | ||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona. | ||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||
|
open in yahoo | open in reuters | open in marketwatch | open in google |
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite